• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆汁分泌受损促进镰状细胞病中的肝胆损伤。

Impaired Bile Secretion Promotes Hepatobiliary Injury in Sickle Cell Disease.

机构信息

Pittsburgh Heart, Lung and Blood Vascular Medicine Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA.

出版信息

Hepatology. 2020 Dec;72(6):2165-2181. doi: 10.1002/hep.31239. Epub 2020 Nov 13.

DOI:10.1002/hep.31239
PMID:32190913
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7923682/
Abstract

BACKGROUND AND AIMS

Hepatic crisis is an emergent complication affecting patients with sickle cell disease (SCD); however, the molecular mechanism of sickle cell hepatobiliary injury remains poorly understood. Using the knock-in humanized mouse model of SCD and SCD patient blood, we sought to mechanistically characterize SCD-associated hepato-pathophysiology applying our recently developed quantitative liver intravital imaging, RNA sequence analysis, and biochemical approaches.

APPROACH AND RESULTS

SCD mice manifested sinusoidal ischemia, progressive hepatomegaly, liver injury, hyperbilirubinemia, and increased ductular reaction under basal conditions. Nuclear factor kappa B (NF-κB) activation in the liver of SCD mice inhibited farnesoid X receptor (FXR) signaling and its downstream targets, leading to loss of canalicular bile transport and altered bile acid pool. Intravital imaging revealed impaired bile secretion into the bile canaliculi, which was secondary to loss of canalicular bile transport and bile acid metabolism, leading to intrahepatic bile accumulation in SCD mouse liver. Blocking NF-κB activation rescued FXR signaling and partially ameliorated liver injury and sinusoidal ischemia in SCD mice.

CONCLUSIONS

These findings identify that NF-κB/FXR-dependent impaired bile secretion promotes intrahepatic bile accumulation, which contributes to hepatobiliary injury of SCD. Improved understanding of these processes could potentially benefit the development of therapies to treat sickle cell hepatic crisis.

摘要

背景与目的

肝危象是影响镰状细胞病(SCD)患者的一种紧急并发症;然而,镰状细胞肝胆损伤的分子机制仍知之甚少。我们使用 SCD 的基因敲入人源化小鼠模型和 SCD 患者的血液,应用我们最近开发的定量肝活体成像、RNA 序列分析和生化方法,试图从机制上描述 SCD 相关的肝病理生理学。

方法和结果

SCD 小鼠在基础条件下表现出窦状隙缺血、进行性肝肿大、肝损伤、高胆红素血症和胆管反应增加。SCD 小鼠肝脏中核因子 kappa B(NF-κB)的激活抑制法尼醇 X 受体(FXR)信号及其下游靶标,导致胆小管胆汁转运和胆汁酸池改变而丧失胆盐转运。活体成像显示胆汁分泌进入胆小管受损,这是由于胆小管胆汁转运和胆汁酸代谢丧失导致肝内胆汁积聚。阻断 NF-κB 激活可挽救 FXR 信号,并部分改善 SCD 小鼠的肝损伤和窦状隙缺血。

结论

这些发现表明,NF-κB/FXR 依赖性胆汁分泌受损促进肝内胆汁积聚,从而导致 SCD 的肝胆损伤。对这些过程的深入了解可能有助于开发治疗镰状细胞肝危象的疗法。

相似文献

1
Impaired Bile Secretion Promotes Hepatobiliary Injury in Sickle Cell Disease.胆汁分泌受损促进镰状细胞病中的肝胆损伤。
Hepatology. 2020 Dec;72(6):2165-2181. doi: 10.1002/hep.31239. Epub 2020 Nov 13.
2
Impaired hemoglobin clearance by sinusoidal endothelium promotes vaso-occlusion and liver injury in sickle cell disease.窦内皮细胞对血红蛋白清除能力受损可促进镰状细胞病中的血管阻塞和肝损伤。
Haematologica. 2024 May 1;109(5):1535-1550. doi: 10.3324/haematol.2023.283792.
3
Network pharmacology-based mechanism prediction and pharmacological validation of Xiaoyan Lidan formula on attenuating alpha-naphthylisothiocyanate induced cholestatic hepatic injury in rats.基于网络药理学的方法预测及 Xiaoyan Lidan 配方对α-萘异硫氰酸酯诱导的大鼠胆汁淤积性肝损伤的药效学验证。
J Ethnopharmacol. 2021 Apr 24;270:113816. doi: 10.1016/j.jep.2021.113816. Epub 2021 Jan 12.
4
Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.杨芽宁通过体内和体外激活法尼醇 X 受体来防止胆汁淤积和肝毒性。
Toxicol Appl Pharmacol. 2018 Jun 1;348:105-116. doi: 10.1016/j.taap.2018.04.015. Epub 2018 Apr 14.
5
Hemoglobin scavenger receptor CD163 as a potential biomarker of hemolysis-induced hepatobiliary injury in sickle cell disease.血红蛋白清道夫受体 CD163 作为镰状细胞病溶血诱导肝胆损伤的潜在生物标志物。
Am J Physiol Cell Physiol. 2024 Aug 1;327(2):C423-C437. doi: 10.1152/ajpcell.00386.2023. Epub 2024 Apr 29.
6
Wedelolactone alleviates cholestatic liver injury by regulating FXR-bile acid-NF-κB/NRF2 axis to reduce bile acid accumulation and its subsequent inflammation and oxidative stress.韦德尔内酯通过调节 FXR-胆汁酸-NF-κB/NRF2 轴减轻胆汁淤积性肝损伤,减少胆汁酸积聚及其随后的炎症和氧化应激。
Phytomedicine. 2024 Jan;122:155124. doi: 10.1016/j.phymed.2023.155124. Epub 2023 Sep 29.
7
Pharmacologic activation of hepatic farnesoid X receptor prevents parenteral nutrition-associated cholestasis in mice.法尼醇 X 受体激动剂可预防小鼠肠外营养相关性胆汁淤积。
Hepatology. 2022 Feb;75(2):252-265. doi: 10.1002/hep.32101. Epub 2021 Dec 7.
8
Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis.泽泻醇B 23-乙酸酯可预防ANIT诱导的肝毒性和胆汁淤积,这是由于FXR介导对参与胆汁酸稳态的转运蛋白和酶的调节作用。
Toxicol Appl Pharmacol. 2015 Mar 15;283(3):178-86. doi: 10.1016/j.taap.2015.01.020. Epub 2015 Feb 3.
9
Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis.肠道中核胆汁酸受体 FXR 的选择性激活可保护小鼠免受胆汁淤积。
Gastroenterology. 2012 Feb;142(2):355-65.e1-4. doi: 10.1053/j.gastro.2011.10.028. Epub 2011 Nov 2.
10
β-Catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis.β-连环蛋白调节法尼醇 X 受体信号和胆汁酸代谢在小鼠胆汁淤积。
Hepatology. 2018 Mar;67(3):955-971. doi: 10.1002/hep.29371. Epub 2018 Jan 26.

引用本文的文献

1
Hepatobiliary complications in patients with sickle cell disease: A 30-year review of 1009 patients.镰状细胞病患者的肝胆并发症:对1009例患者的30年回顾
Hepatol Commun. 2025 Apr 30;9(5). doi: 10.1097/HC9.0000000000000712. eCollection 2025 May 1.
2
GBT1118, a Voxelotor Analog, Ameliorates Hepatopathy in Sickle Cell Disease.GBT1118,一种伏洛托拉肖类似物,可改善镰状细胞病中的肝病。
Medicina (Kaunas). 2024 Sep 26;60(10):1581. doi: 10.3390/medicina60101581.
3
Hemoglobin scavenger receptor CD163 as a potential biomarker of hemolysis-induced hepatobiliary injury in sickle cell disease.血红蛋白清道夫受体 CD163 作为镰状细胞病溶血诱导肝胆损伤的潜在生物标志物。
Am J Physiol Cell Physiol. 2024 Aug 1;327(2):C423-C437. doi: 10.1152/ajpcell.00386.2023. Epub 2024 Apr 29.
4
Impaired hemoglobin clearance by sinusoidal endothelium promotes vaso-occlusion and liver injury in sickle cell disease.窦内皮细胞对血红蛋白清除能力受损可促进镰状细胞病中的血管阻塞和肝损伤。
Haematologica. 2024 May 1;109(5):1535-1550. doi: 10.3324/haematol.2023.283792.
5
Long-Term L-Glutamine Treatment Reduces Hemolysis without Ameliorating Hepatic Vaso-Occlusion and Liver Fibrosis in a Mouse Model of Sickle Cell Disease.长期L-谷氨酰胺治疗可减少镰状细胞病小鼠模型中的溶血,但不能改善肝血管闭塞和肝纤维化。
Biomedicines. 2023 Aug 29;11(9):2412. doi: 10.3390/biomedicines11092412.
6
Mouse models of sickle cell disease: Imperfect and yet very informative.镰状细胞病的小鼠模型:不完美但却非常有信息价值。
Blood Cells Mol Dis. 2024 Jan;104:102776. doi: 10.1016/j.bcmd.2023.102776. Epub 2023 Jun 17.
7
Urine metabolomics and microbiome analyses reveal the mechanism of anti-tuberculosis drug-induced liver injury, as assessed for causality using the updated RUCAM: A prospective study.尿液代谢组学和微生物组学分析揭示了抗结核药物性肝损伤的作用机制,采用更新的 RUCAM 评估因果关系:一项前瞻性研究。
Front Immunol. 2022 Nov 22;13:1002126. doi: 10.3389/fimmu.2022.1002126. eCollection 2022.
8
Molecular mechanisms of hepatic dysfunction in sickle cell disease: lessons from Townes mouse model.镰状细胞病肝功能障碍的分子机制:来自 Townes 小鼠模型的启示。
Am J Physiol Cell Physiol. 2022 Aug 1;323(2):C494-C504. doi: 10.1152/ajpcell.00175.2022. Epub 2022 Jun 27.
9
Liver-to-lung microembolic NETs promote gasdermin D-dependent inflammatory lung injury in sickle cell disease.肝到肺的微栓子 NETs 通过依赖于 gasdermin D 的炎症反应促进镰状细胞病的肺部损伤。
Blood. 2022 Sep 1;140(9):1020-1037. doi: 10.1182/blood.2021014552.
10
Intravital imaging reveals inflammation as a dominant pathophysiology of age-related hepatovascular changes.活体成像揭示炎症是与年龄相关的肝血管变化的主要病理生理学。
Am J Physiol Cell Physiol. 2022 Mar 1;322(3):C508-C520. doi: 10.1152/ajpcell.00408.2021. Epub 2022 Jan 5.

本文引用的文献

1
Pathophysiology of Sickle Cell Disease.镰状细胞病的病理生理学。
Annu Rev Pathol. 2019 Jan 24;14:263-292. doi: 10.1146/annurev-pathmechdis-012418-012838. Epub 2018 Oct 17.
2
Dysregulated Bile Transporters and Impaired Tight Junctions During Chronic Liver Injury in Mice.在慢性肝损伤过程中,小鼠的胆汁转运体失调和紧密连接受损。
Gastroenterology. 2018 Oct;155(4):1218-1232.e24. doi: 10.1053/j.gastro.2018.06.048. Epub 2018 Jun 30.
3
Dual catenin loss in murine liver causes tight junctional deregulation and progressive intrahepatic cholestasis.双重连环蛋白缺失导致小鼠肝脏紧密连接调节紊乱和进行性肝内胆汁淤积。
Hepatology. 2018 Jun;67(6):2320-2337. doi: 10.1002/hep.29585. Epub 2018 Apr 19.
4
Sickle cell intrahepatic cholestasis unresponsive to exchange blood transfusion: a case report.对换血治疗无反应的镰状细胞性肝内胆汁淤积症:一例报告
Rev Bras Hematol Hemoter. 2017 Apr-Jun;39(2):163-166. doi: 10.1016/j.bjhh.2017.02.006. Epub 2017 Mar 11.
5
Sickle cell disease.镰状细胞病。
Lancet. 2017 Jul 15;390(10091):311-323. doi: 10.1016/S0140-6736(17)30193-9. Epub 2017 Feb 1.
6
Pro-inflammation NF-κB signaling triggers a positive feedback via enhancing cholesterol accumulation in liver cancer cells.促炎核因子-κB信号通过增强肝癌细胞中的胆固醇积累触发正反馈。
J Exp Clin Cancer Res. 2017 Jan 18;36(1):15. doi: 10.1186/s13046-017-0490-8.
7
Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli.镰状细胞病中的肺血管阻塞是由小动脉中性粒细胞-血小板微栓子介导的。
JCI Insight. 2017 Jan 12;2(1):e89761. doi: 10.1172/jci.insight.89761.
8
Genetic Modifiers of White Blood Cell Count, Albuminuria and Glomerular Filtration Rate in Children with Sickle Cell Anemia.镰状细胞贫血患儿白细胞计数、蛋白尿和肾小球滤过率的基因修饰因子
PLoS One. 2016 Oct 6;11(10):e0164364. doi: 10.1371/journal.pone.0164364. eCollection 2016.
9
Nuclear factor-κB regulates the expression of multiple genes encoding liver transport proteins.核因子-κB调控多个编码肝脏转运蛋白的基因的表达。
Am J Physiol Gastrointest Liver Physiol. 2016 Apr 15;310(8):G618-28. doi: 10.1152/ajpgi.00363.2015. Epub 2016 Feb 11.
10
Interactions of sickle red blood cells with neutrophils are stabilized on endothelial cell layers.镰状红细胞与中性粒细胞的相互作用在内皮细胞层上得以稳定。
Blood Cells Mol Dis. 2016 Jan;56(1):38-40. doi: 10.1016/j.bcmd.2015.10.006. Epub 2015 Nov 6.